M11.16 Familial chondrocalcinosis, knee

Name of the Condition

• Familial chondrocalcinosis, knee

Summary

Familial chondrocalcinosis, knee is a hereditary condition characterized by the deposition of calcium pyrophosphate dihydrate (CPPD) crystals in the knee joint and surrounding tissues. This leads to inflammation, pain, and potential joint damage. It is part of the broader group of crystal arthropathies and is distinguished by its familial inheritance pattern and knee-specific involvement. Diagnosis typically involves clinical evaluation, imaging, and sometimes crystal identification in joint fluid or tissue.

Causes

Familial chondrocalcinosis, knee is caused by genetic mutations that influence calcium pyrophosphate crystal formation in the knee’s cartilage, synovium, or periarticular structures. These mutations may affect enzymes or proteins involved in crystal metabolism, leading to abnormal crystal deposition. The condition is inherited, though the exact genetic pathways vary.

Risk Factors

• Family history of chondrocalcinosis or related crystal arthropathies.
• Advanced age (increases likelihood of crystal deposition).
• Metabolic conditions affecting calcium or phosphate levels.
• Knee trauma or surgery (may trigger crystal release).
• Chronic inflammatory joint diseases.

Symptoms

• Knee pain, swelling, and stiffness.
• Recurrent episodes of acute inflammation.
• Reduced range of motion in the knee.
• Joint crepitus (grinding sensation) during movement.

Diagnosis

Diagnosis of familial chondrocalcinosis, knee involves a combination of clinical assessment, imaging studies (e.g., X-rays, ultrasound, or MRI), and laboratory tests. Imaging may reveal characteristic crystal deposits or joint changes. Joint fluid analysis to identify CPPD crystals under polarized light microscopy can confirm the diagnosis. Genetic testing may be considered in cases with a strong family history.

Treatment Options

Treatment focuses on managing symptoms and reducing inflammation. Nonsteroidal anti-inflammatory drugs (NSAIDs) or colchicine may alleviate acute flares. Intra-articular corticosteroid injections can provide targeted relief for knee inflammation. Physical therapy helps maintain joint function and mobility. Long-term management may include addressing underlying metabolic conditions or genetic counseling for familial cases.

Prognosis and Follow-Up

The prognosis varies depending on the severity of joint involvement and response to treatment. Early diagnosis and management can help control symptoms and slow joint damage. Regular follow-up with a healthcare provider is recommended to monitor joint function, adjust treatment, and address any complications. Lifestyle modifications and adherence to prescribed therapies improve outcomes.

Complications

Potential complications include chronic knee pain, progressive joint degeneration (osteoarthritis), reduced mobility, and recurrent acute flares. In severe cases, joint deformity or disability may occur. Prompt treatment of acute episodes and ongoing management reduce the risk of long-term damage.

Lifestyle & Prevention

Maintaining a healthy weight reduces stress on the knee joint. Low-impact exercises (e.g., swimming, cycling) preserve mobility without exacerbating symptoms. Avoiding activities that strain the knee (e.g., heavy lifting or high-impact sports) may help. Managing metabolic conditions (e.g., hyperparathyroidism) and staying hydrated support joint health. Genetic counseling is advised for families with a history of the condition.

When to Seek Professional Help

Seek medical attention if knee pain is severe, persistent, or worsening; if swelling or redness develops; or if mobility is significantly impaired. Acute flares with intense pain, fever, or inability to bear weight require prompt evaluation. Regular check-ups are recommended for those with a family history or diagnosed condition to monitor joint health.

Tips for Medical Coders

Use code M11.16 for familial chondrocalcinosis specifically affecting the knee. Document the site (knee) and familial nature to support coding accuracy. Ensure clinical documentation confirms the hereditary aspect and knee involvement, as this distinguishes it from non-familial or site-unspecified cases. Verify that no other site-specific codes apply before assigning M11.16.